8-K - Galera Therapeutics, Inc. - 1.01 / 3.02 / 5.01 / 7.01 / 9.01

Form 8-K - Current report: SEC Accession No. 0001193125-26-154009

Filing Date: 2026-04-14

Accepted: 2026-04-14 09:18:07

Documents: 38

Period of Report: 2026-04-14

Items: Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.01: Changes in Control of Registrant Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Galera Therapeutics, Inc. (Filer) CIK : 0001563577 (see all company filings) EIN. : 461454898 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 26859356 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | d124753d8k.htm iXBRL | 8-K

2 | EX-2.1 | d124753dex21.htm | EX-2.1

3 | EX-10.1 | d124753dex101.htm | EX-10.1

4 | EX-10.2 | d124753dex102.htm | EX-10.2